TAMEMs highly express mitogenic and angiogenic factors (e.g., VEGF, PDGF, and Ang) and immunosuppressive cytokines (e.g., IL‐10, CCL17, and TGF‐β), comparable to those in TAMs, which are typical features of the latter in promoting tumor development (Liu & Cao, 2015). This evidence concerns the gene TGFB1 and neoplasm.